Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up

Purpose: To evaluate the treatment solutions and effectiveness of intravitreal ranibizumab (RBZ) or conbercept in patients with wet age-related macular degeneration (wAMD) in a real-life setting in China.Methods: The medical records of 368 patients with wAMD who started RBZ or conbercept treatment b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yan Lu, Wenzhi Huang, Yuehong Zhang, Xiongfei Huang, Xu Zhang, Haizhi Ma, Guoliang Ren, Feng Shi, Lihui Kuang, Shigang Yan, Shuke Luo, Junyan Zhang, Jingfang He, Weizhong Yang, Zongyin Gao, Yunxia Leng
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
age-related macular degeneration
ranibizumab
conbercept
polypoidal choroidal vasculopathy (PCV)
choroidal neovascularization (CNV)
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/ac9e16d329af4ba2be07b0a004af0630
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares